Cellular and humoral response after MRNA‐1273 SARS‐CoV‐2 vaccine in kidney transplant recipients

According to preliminary data, seroconversion after mRNA SARS‐CoV‐2 vaccination might be unsatisfactory in Kidney Transplant Recipients (KTRs). However, it is unknown if seronegative patients develop at least a cellular response that could offer a certain grade of protection against SARS‐CoV‐2. To a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of transplantation 2021-08, Vol.21 (8), p.2727-2739
Hauptverfasser:	Cucchiari, David, Egri, Natalia, Bodro, Marta, Herrera, Sabina, Del Risco‐Zevallos, Jimena, Casals‐Urquiza, Joaquim, Cofan, Frederic, Moreno, Asunción, Rovira, Jordi, Banon‐Maneus, Elisenda, Ramirez‐Bajo, Maria J., Ventura‐Aguiar, Pedro, Pérez‐Olmos, Anna, Garcia‐Pascual, Marta, Pascal, Mariona, Vilella, Anna, Trilla, Antoni, Ríos, José, Palou, Eduard, Juan, Manel, Bayés, Beatriu, Diekmann, Fritz
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Viral clinical research / practice COVID-19 COVID-19 Vaccines Diabetes mellitus Enzyme-linked immunosorbent assay Globulins Humans Immune response (humoral) Immunization Immunoglobulin G Immunoglobulin M infection and infectious agents ‐ viral infectious disease Kidney transplantation Kidney Transplantation - adverse effects kidney transplantation / nephrology Kidney transplants mRNA Original ORIGINAL ARTICLES Pancreas Patients RNA, Messenger - genetics SARS-CoV-2 Seroconversion Severe acute respiratory syndrome coronavirus 2 Vaccination vaccine Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!